Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated with HD
Phase 1
Terminated
- Conditions
- Huntington Disease
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Fundacion Huntington Puerto Rico
- Target Recruit Count
- 36
- Registration Number
- NCT04301726
- Locations
- 🇵🇷
Fundacion Huntington Puerto Rico, Inc. - Huntington's disease Clinic, San Juan, Puerto Rico
News
No news found